Stocktoria
AbbVie Inc. ABBV
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2013-01-02
AbbVie Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% |
| Net margin | 6.9% | 7.6% | 9.0% | 20.4% | 20.5% |
| FCF margin | 29.1% | 31.7% | 40.6% | 41.8% | 39.1% |
| Return on assets | 3.2% | 3.2% | 3.6% | 8.5% | 7.9% |
| Return on equity | -129.2% | 127.2% | 46.8% | 68.5% | 74.8% |
| Debt / equity | -19.73× | 19.87× | 5.70× | 3.65× | 4.92× |
| Current ratio | 0.67 | 0.66 | 0.87 | 0.96 | 0.79 |
| Revenue growth | 8.6% | 3.7% | -6.4% | 3.3% | 22.7% |
Source: SEC EDGAR filings · CIK 0001551152 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.